Tag: Galectin Therapeutics

September 20, 2018

Galectin Therapeutics Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA

Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, and Providence Cancer Institute today announced additional preliminary clinical data from...
September 9, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Soars 83 Percent

MannKind, Evofem Biosciences, Arbutus Biopharma, Infinity Pharmaceuticals and VBI Vaccines were last week's top gainers on the NASDAQ Biotechnology Index.
July 9, 2018

5 Top NASDAQ Biotech Stocks of Q2 2018

The biotech industry is a unique intersection of companies. Here's a look at the top-gaining biotech companies on the NASDAQ...
July 9, 2018

5 Top NASDAQ Biotech Stocks of Q2 2018

The biotech industry is a unique intersection of companies. Here's a look at the top-gaining biotech companies on the NASDAQ...
June 27, 2018

Galectin Therapeutics Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis

Galectin Therapeutics (NASDAQ:GALT) the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that...
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
June 5, 2018

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the...